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Abstract
Background: Endothelial cells (EC) in tumor and normal tissue constitute critical radiotherapy targets. MicroRNAs
have emerged as master switchers of the cellular transcriptome. Here, we seek to investigate the role of miRNAs in
primary human dermal microvascular endothelial cells (HDMEC) after ionizing radiation.
Methods: The microRNA status in HDMEC after 2 Gy radiation treatment was measured using oligo-microarrays
covering 361 miRNAs. To functionally analyze the role of radiation-induced differentially regulated miRNAs, cells
were transfected with miRNA precursor or inhibitor constructs. Clonogenic survival and proliferation assays were
performed.
Results: Radiation up-regulated miRNA expression levels included let-7g, miR-16, miR-20a, miR-21 and miR-29c,
while miR-18a, miR-125a, miR-127, miR-148b, miR-189 and miR-503 were down-regulated. We found that
overexpression or inhibition of let-7g, miR-189, and miR-20a markedly influenced clonogenic survival and cell
proliferation per se. Notably, the radiosensitivity of HDMEC was significantly influenced by differential expression of
miR-125a, -127, -189, and let-7g. While miR-125a and miR-189 had a radioprotective effect, miR-127 and let-7g
enhanced radiosensitivity in human endothelial cells.
Conclusion: Our data show that ionizing radiation changes microRNA levels in human endothelial cells and,
moreover, exerts biological effects on cell growth and clonogenicity as validated in functional assays. The data also
suggest that the miRNAs which are differentially expressed after radiation modulate the intrinsic radiosensitivity of
endothelial cells in subsequent irradiations. This indicates that miRNAs are part of the innate response mechanism
of the endothelium to radiation.
Background
MicroRNAs (miRNAs, miRs) are a group of short, non-
coding RNAs (~22 nucleotides in length) that have
emerged as important (negative) regulators of gene
expression. It has been shown that up to 100-200
mRNAs can be repressed by one miRNA [1]. These
molecules are considered key players in a variety of pro-
cesses ranging from development, proliferation, morpho-
genesis and differentiation to cancer and apoptosis [2,3].
Roles of microRNAs in cancer development have been
documented in several studies [4,5]. Typically, miRNAs
involved in tumorigenesis are deregulated, and this
deregulation is believed to alter the expression of pro-
tein-coding mRNA, thereby favoring uncontrolled
tumor cell growth. The deregulation can be an under-
or overexpression, suggesting that miRNAs may func-
tion as tumor suppressors or as oncogenes. The involve-
ment of miRNAs in tumorigenesis is not the only topic
of investigation. In addition the expression patterns of
these regulators by cancer treatment modalities such as
radiotherapy or chemotherapy are increasingly recog-
nized. It has been shown for cancer cells that the
expression of miRNAs may vary depending on para-
meters like cell type, post-radiation time and radiation
dose [6-8].
The tumor vessel system, and in turn endothelial cells
as the characteristic parts of the vessel system, consti-
tute critical targets for radiotherapy of tumors. However,
to our best knowledge, the regulation of miRNAs in
endothelial cells (EC) after radiation has not been inves-
tigated to date. EC are sensitive to ionizing radiation in
proliferation and clonogenic assays in vitro and in vivo
[9] and may constitute critical targets in normal tissue
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such as in the gut microvasculature [10]. In contrast, EC
are also stimulated by radiation-induced indirect pro-
angiogenic factor production including VEGF and bFGF
[9,11]. Further ionizing radiation potently causes DNA
damage, which has been shown to induce miRNA
expression via the p53 network [12]. Here we investi-
gated the miRNA response in EC after ionizing radia-
tion. To this end, human EC were irradiated and
radiation-induced alterations of miRNA levels were ana-
lyzed by miRNA microarrays. The most stringently
regulated miRNAs were then further analyzed. The
effects of miRNA overexpression or inhibition were
determined in functional assays including clonogenic
assays with and without radiation in order to examine if




Human dermal microvascular endothelial cells
(HDMEC; PromoCell, Heidelberg, Germany) were cul-
tured in modified PromoCell medium (for ref. see [13])
for optimal growth results. Cells were cultured up to
passage 7; for transfection cells of passage 3 to 5 were
used.
Isolation of RNA
Cells were seeded in culture flasks until confluency of
~70% before 2 Gy photon irradiation (RT, 6 MeV;
LINAC, Siemens). After RT they were transferred back
to the incubator and after 6 hours lysed and stored at
-80°C. Non-irradiated cells were used as controls. RNA
was isolated from HDMEC using TRIzol LS reagent
(Invitrogen, Karlsruhe, Germany) (3 biological replicates
each for RT and control) as described by the manufac-
turers. Quality and quantity of isolated RNA were
checked using Lab on Chip technology on Agilent 2100
bioanalyzer (Agilent technologies, CA, USA) and a
Nanodrop spectrophotometer (ND-1000; Nanodrop
technologies, DE, USA).
Locked nucleic acid (LNA) -based miRNA microarrays and
data analysis
RNA samples from the three biological replicates were
used for LNA-based array analysis. miRNA expression
profiling was performed using a microarray platform
which is based on locked nucleic acid (LNA)-modified
capture probes which are immobilized on the chip sur-
face. For detailed protocol and further details see Cas-
toldi et al. [14] and Exiqon (http://www.exiqon.com).
361 miRNAs, including 315 human miRNAs were
spotted in quadruplicates on the slides (see Additional
file 1). Slides were scanned using the Genepix 4000B
scanner (Axon instruments). Data analyses were done
using ‘Microsoft Excel’ software and the ‘SUMO’ soft-
ware package for microarray data evaluation (http://
www.oncoexpress.de/software/sumo/). For data normali-
zation we developed a step-wise approach: First, normal-
ization was performed on the background-subtracted
mean intensity values against the intensity of the U6
snRNA spots on each chip. After this thresholding, the
data underwent a two-class t-test. We then created a
short-list of differentially expressed miRNAs as
described in ‘Results’. Microarray data were deposited in
‘ArrayExpress’ (accession no.: E-TABM-617).
Transfection
Transfection of primary HDMEC was performed using
the siPORT Amine (Ambion, Texas, USA) transfection
reagent. Transfection efficiency was analyzed using a
GAPDH assay (KDalert, Ambion). The efficiency of
transfection conditions was 30-50%. Furthermore a miR-
1 transfection test system (Ambion) was used, which is
known to down-regulate the PTK9 mRNA in human
cells. Expression of PTK9 was measured by real-time
PCR to verify our transfection conditions (see Addi-
tional file 2). In the experiments miRNA precursor (pre-
miR) or inhibitor (anti-miR) molecules or the appropri-
ate negative control molecules were added to the cells
in a final concentration of 50 nM. The following pre-
and anti-miRs were used: hsa-let-7g, hsa-miR-125a, hsa-
miR-127, hsa-miR-148b, hsa-miR-189, hsa-miR-20a, pre-
miR negative control #1, and anti-miR negative control
#1 (all purchased from Ambion).
Clonogenic survival assay
HDMEC were pre-plated in 25 cm2 cell culture flasks;
cell numbers varied depending on the treatment. In
experimental settings with transfection medium and/or
RT cell numbers were raised. After one day the transfec-
tion mixture was added for 6 hours, then cells were re-
fed with normal growth medium. After 24 hours cells
were irradiated with 2 Gy (6 MeV X-rays; LINAC, Sie-
mens) and then returned to the incubator for 8-10 days.
Untreated cells served as growth controls. For evaluation
the number of counted colonies was normalized to the
amount of pre-plated cells. At the end of the incubation
period cells were stained with crystal violet (Sigma-
Aldrich, Germany) and colonies were counted. All con-
ditions were done in triplicate, the survival experiments
for each miRNA were repeated three times.
Proliferation assay
The proliferation rate of cells was determined using a
calcein assay (PromoKine, Heidelberg, Germany). The
assay was performed in a 96 well-plate format. 2500
endothelial cells were seeded per well, after 1 day they
were transfected for 6 hours, cultured with normal
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growth medium and incubated for another 24 hours.
Then the cells were irradiated with 2 or 10 Gy - while
controls were non-irradiated - and incubated for 3 days.
Intracellular fluorescent calcein is directly proportional
to the number of living cells and was measured using a
plate reader (CytoFluor, PerSeptive Biosystems) with
485 nm excitation and 530 nm emission filters.
Statistical analysis
Statistical data evaluation was performed using two-
tailed t-tests or in case of multiple comparisons using
ANOVA along with Fisher’s least significance difference
test. The significance level was P < 0.05.
Results
miRNA array data
The miRNA expression profile of HDMEC six hours
after 2 Gy radiation treatment (RT) was analyzed using
oligo-microarrays. For data analysis we generated a
short-list of the most stringently regulated miRNAs (p-
value < 0.05) using a t-test and identified 83 genes.
Because each miRNA was spotted four times on a chip,
we selected those which were present three or four
times in our short-list and which had a minimum spot
intensity value of 1000. Finally, we identified 11 miRNAs
from the t-test and considered them as regulated by
irradiation at the dose of 2 Gy (Tab. 1). In terms of ‘fold
change’ the regulation revealed small but statistically sig-
nificant values (p-value of 0.05 or lower) between 0.5-
and 1.5-fold (Fig. 1).
Endothelial cell response to miRNA overexpression and
inhibition
Clonogenic survival assays
Out of the microRNA list from the microarrays we
selected six miRNAs (let-7g, miR-125a, miR-127, miR-
148b, miR-189, and miR-20a) for further functional
analysis.
We found that the overexpression or inhibition, respec-
tively, of miR-189, let-7g and miR-20a showed the stron-
gest effects on functional cell behavior. In comparison to
respective unspecific control molecules, miR-189 precur-
sor strongly inhibited clonogenic survival in HDMEC (P
< 0.05) (Fig. 2). In contrast, we observed different effects
after additional radiation of the cells: Pretreatment of
cells with miR-189 precursor prior to a 2 Gy radiation
treatment caused an increase of clonogenic survival,
while a pretreatment with miR-189 inhibitor caused a
reduction in clonogenic survival (P < 0.05).
Table 1 miRNA species altered in HDMEC in response to
radiation (2 Gy)












Microarray data of radiation treated versus untreated cells; t-test was
performed with 3 biological replicates each. Each ‘fold change’ value
represents a medium of 3-4 individual spot values.
Figure 1 Differentially expressed miRNAs in HDMEC. The figure
includes those miRNAs which are listed in Tab. 1. The heat-map
was generated via a t-test of microarray data of radiation treated
versus untreated cells. Each column represents the medium value of
three biological replicates. Colours represent log2 values from -1.5
to 1.5.
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We also found that overexpression and inhibition,
respectively, of let-7g had similar effects on clonogenic
survival like miR-189 (Fig. 3). The addition of pre-let-7g
caused a dramatic reduction by ~50% of clones. Anti-
let-7g had the opposite effect and enhanced the clono-
genic survival (P < 0.05). After irradiation the same pat-
tern was observed: Overexpression of let-7g further
reduced clonogenic survival of cells irradiated with 2 Gy
vs. irradiated controls, while let-7g inhibition signifi-
cantly improved clonogenic survival (P < 0.05) vs. irra-
diated controls (Fig. 3, right panel).
Furthermore, we measured in non-irradiated EC a
strong inhibition of clonogenic survival by pre-miR-20a,
while the downregulation of the miR-20a level increased
the number of clones (P < 0.05) (Fig. 4). Although the
direct functional effects of miR-20a over- or underex-
pression were strong, the clonogenicity upon irradiation
was not markedly affected.
For miR-125a and -127 we found that the downregu-
lation of the miRNA levels caused a significant reduc-
tion (P < 0.05) of clonogenic survival (Figs. 5 and 6, left
panels). The overexpression of miR-125a or miR-127
showed no marked effects on clonogenicity per se. How-
ever, the altered expression significantly influenced the
response to radiation: Pre-miR-125a enhanced the num-
ber of clones compared to irradiated mock control cells,
Figure 2 Clonogenic survival of HDMEC after transfection with miR-189 precursor or inhibitor. Cells were treated as described in
‘Methods’. Bar charts: Left sided: Influence of the transfected molecules on clonogenic survival without RT. Negative controls were set 100%.
Right sided: Survival of irradiated cells (2 Gy) after transfection with the miRNA precursor (pre-miR) or inhibitor (anti-miR). Only miR transfected
samples without irradiation were set 100%. Bars: Mean (n = 3) with SD. *: P < 0.05 versus the pre-miR or anti-miR negative control.
Figure 3 Clonogenic survival of HDMEC after transfection with let-7g precursor or inhibitor. Cells were treated as described in ‘Methods’.
Bar charts: Left sided: Influence of the transfected molecules on clonogenic survival without RT. Negative controls were set 100%. Right sided:
Survival of irradiated cells (2 Gy) after transfection with the miRNA precursor (pre-miR) or inhibitor (anti-miR). Only miR transfected samples
without irradiation were set 100%. Bars: Mean (n = 3) with SD. *: P < 0.05 versus the pre-miR or anti-miR negative control.
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while anti-miR-125a reduced clonogenic survival (P <
0.05) (Fig. 5, right panel). miR-127 overexpression had a
strong negative effect on clonogenic survival in 2 Gy
treated cells (P < 0.05) (Fig. 6, right panel).
In the experiments with miR-148b we mainly observed
an inhibitory effect of anti-miR-148b on clonogenic sur-
vival in non-irradiated cells (Fig. 7).
Cell proliferation/viability assays
Aside from clonogenic survival we also studied cell pro-
liferation as a functional endpoint. In Fig. 8 the effects
of ionizing radiation after transfection with precursors
or inhibitors of miR-189, let-7g and miR-20a are shown.
As for clonogenicity, overexpression or inhibition of
miRNAs significantly altered endothelial cell properties
in response to radiation. The viability of the cells after
RT was checked by light microscopy. While EC treated
with 2 Gy apparently did not show visible alterations
compared to the untreated cells, cells treated with 10
Gy showed typical signs of cell stress, like cytoplasmic
contraction, but were still adherent. After 10 Gy radia-
tion treatment the number of cells always was somewhat
reduced compared to the 2 Gy treatment. The degree of
Figure 4 Clonogenic survival of HDMEC after transfection with miR-20a precursor or inhibitor. Cells were treated as described in
‘Methods’. Bar charts: Left sided: Influence of the transfected molecules on clonogenic survival without RT. Negative controls were set 100%.
Right sided: Survival of irradiated cells (2 Gy) after transfection with the miRNA precursor (pre-miR) or inhibitor (anti-miR). Only miR transfected
samples without irradiation were set 100%, except for pre-miR-20a. Bars: Mean (n = 3) with SD. *: P < 0.05 versus the pre-miR or anti-miR
negative control.
Figure 5 Clonogenic survival of HDMEC after transfection with miR-125a precursor or inhibitor. Cells were treated as described in
‘Methods’. Bar charts: Left sided: Influence of the transfected molecules on clonogenic survival without RT. Negative controls were set 100%.
Right sided: Survival of irradiated cells (2 Gy) after transfection with the miRNA precursor (pre-miR) or inhibitor (anti-miR). Only miR transfected
samples without irradiation were set 100%. Bars: Mean (n = 3) with SD. *: P < 0.05 versus the pre-miR or anti-miR negative control.
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reduction was dependent on the various transfection
treatments.
While the overexpression of miR-189 had no signifi-
cant effect on the proliferation of irradiated cells com-
pared to the negative control (Fig. 8A) proliferation
decreased further after transfection with anti-miR-189
vs. the respective negative control (P < 0.05). This
alteration was in particular found at 2 Gy. At the high
radiation dose of 10 Gy this differential effect was hardly
present any longer.
As shown in Fig. 8B, overexpression of let-7g further
reduced cell number after irradiation with 2 Gy in
comparison to the control miRNA. In contrast, the inhi-
bition of let-7g attenuated the growth inhibitory effect
of the radiation treatment at the dose of 2 Gy. This pro-
survival effect in endothelial cells of anti-let-7g was also
present in the 10 Gy radiation setting (P < 0.05).
In the case of miR-20a the effects on clonogenicity
and proliferation were remarkably different: Compared
to the strong inhibitory effect of miR-20a precursor on
clonogenic survival the proliferation inhibition of irra-
diated cells was much more moderate, but significant
(Fig. 8C). miR-20a inhibition showed the opposite effect
in cells with 2 Gy RT.
Figure 6 Clonogenic survival of HDMEC after transfection with miR-127 precursor or inhibitor. Cells were treated as described in
‘Methods’. Bar charts: Left sided: Influence of the transfected molecules on clonogenic survival without RT. Negative controls were set 100%.
Right sided: Survival of irradiated cells (2 Gy) after transfection with the miRNA precursor (pre-miR) or inhibitor (anti-miR). Only miR transfected
samples without irradiation were set 100%. Bars: Mean (n = 3) with SD. *: P < 0.05 versus the pre-miR or anti-miR negative control.
Figure 7 Clonogenic survival of HDMEC after transfection with miR-148b precursor or inhibitor. Cells were treated as described in
‘Methods’. Bar charts: Left sided: Influence of the transfected molecules on clonogenic survival without RT. Negative controls were set 100%.
Right sided: Survival of irradiated cells (2 Gy) after transfection with the miRNA precursor (pre-miR) or inhibitor (anti-miR). Only miR transfected
samples without irradiation were set 100%. Bars: Mean (n = 3) with SD. *: P < 0.05 versus the pre-miR or anti-miR negative control.
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Taken together, as shown in both proliferation and
clonogenicity assays, the overexpression or inhibition of
radiation-inducible miRNAs markedly changes func-
tional cell behavior, and alters the intrinsic properties of
endothelial cells. Moreover, in both assays the functional
radiosensitivity of endothelial cells is modified after irra-
diation by altered radiation-induced miRNAs.
Discussion
The expression profiling by microarray showed that irra-
diation at the clinically relevant dose of 2 Gy induced
significant changes in miRNA levels in human dermal
microvascular endothelial cells (HDMEC). Six micro-
RNAs (miRs) were chosen for subsequent functional
analyses (let-7g, miR-125a, miR-127, miR-148b, miR-
189, and miR-20a).
The proliferation and clonogenic assays documented
that overexpression or inhibition of the here identified
miRNAs is capable of reducing or enhancing endothelial
cell proliferation and/or clonogenic survival. Moreover,
we also found that overexpression or inhibition of
selected miRNAs either enhanced or attenuated the
radiation-induced reduction of clonogenicity or prolif-
eration of HDMEC. This indicates that changes in radia-
tion-induced miRNA expression alter the intrinsic
functional cell properties and suggest that the radiosen-
sitivity of endothelial cells itself is modified after irradia-
tion. We conclude that radiation-induced miRNA
expression alterations may play important roles in the
desired and, potentially, also in side effects of radiother-
apy of cancer and other applications of ionizing
radiation.
One of the up-regulated miRNAs in response to radia-
tion was a member of the let-7 family (let-7g). Other
let-7 family members were not regulated upon radiation
treatment (RT) or slightly up-regulated like let-7d and
Figure 8 Proliferation assay of irradiated cells. HDMEC were treated as described in ‘Methods’. Panels A-C show the proliferation data of cells
pre-treated with precursor or inhibitor molecules of miR-189, let-7g and miR-20a. The bar charts present the mean proliferation of HDMEC after
irradiation, dependent on the pre-treatment. Fluorescence values are set in percentage related to non-irradiated cells (100%). Bars: Mean (n = 24)
with SD. *: P < 0.05 versus the pre-miR or anti-miR negative control.
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let-7f (see Additional file 3). A role of let-7 in cell
growth has been described in normal and lung cancer
cells, in which let-7 is down-regulated [15]. Let-7 nega-
tively regulates human Ras genes and it was reported
that it is a negative regulator of cell proliferation path-
ways in human cells [16]. An alteration in the expres-
sion of let-7 miRNAs in response to radiation was
recently shown in human fibroblasts [17]. Furthermore,
a role of several let-7 miRNA family members for radia-
tion sensitivity in lung cancer cells was reported by
Weidhaas et al. The authors showed that overexpression
of let-7g protected A549 cells from radiation. Corre-
sponding to the let-7g up-regulation in our irradiated
endothelial cells we found a reduction of clonogenic
survival by overexpression of the miRNA. We found
enhanced survival by inhibition of let-7g both in
untreated and in irradiated cells. The data suggest that
let-7g negatively regulates EC growth and furthermore
sensitizes them to radiation. Since radiation up-regulates
let-7g, the data also indicate that the miRNA up-regula-
tion is correlatively or causatively associated with the
direct anti-endothelial radiation effect as determined by
clonogenic survival and proliferation inhibition.
miR-20a was also found to be up-regulated after radia-
tion treatment. This microRNA sequence lies within the
cluster miR-17-92, which is up-regulated in several
human tumor types including lung, pancreas, prostate
and colon cancer [18]. Matsubara et al. could show that
the inhibition of miR-20a can induce apoptosis in lung
cancer cells over-expressing the miR-17-92 cluster [19].
Furthermore, miR-20a is involved in cell cycle progres-
sion [20]. Our own cell-based assays clearly show that
miR-20a overexpression dramatically inhibits clonogenic
survival, while the inhibition of the miRNA increased
survival rates. Again, since radiation was clearly found
to up-regulate miR-20a, this microRNA is another
potential candidate in our system linking functional cell
death with effects of radiation. Interestingly, our data
showed that the radiation sensitivity itself in endothelial
cells does not appear to be markedly dependent on the
expression level of miR-20a.
The microRNAs miR-189, -125a, -127 and 148b were
all found to be down-regulated after RT of 2 Gy. In the
case of miR-189 the functional experiments revealed
interesting opposite effects on cell growth with and
without radiation: In survival assays we observed a
strong decrease of clonogenic survival after overexpres-
sion of miR-189. In contrast, versus additional radiation
as control sample, miR-189 over-expression increased
clone number and miR-189 inhibition decreased clone
number. These data suggest that miR-189 expression
per se has negative effects on clonogenic survival and
proliferation of endothelial cells. Radiation decreases the
expression levels, which suggests that the anti-
endothelial effects are associated with down-regulated
miRNA expression. Moreover, and in line with these
functional findings, miR-189 up-regulation seems to
exert protective effects against radiation with an
attenuation of radiation-induced growth inhibition.
In functional assays with miR-125a, -127 and -148b
we observed weaker effects of miR overexpression or
inhibition. According to our own results miR-125a is
also differentially expressed in human fibroblasts by
hydrogen peroxide (H2O2), which is like ionizing radia-
tion a stressor for cells [17]. When changing levels of
miR-125a we found a decrease of clonogenic survival
upon inhibition. Similar to miR-189, miR-125a had a
positive effect on endothelial clonogenic survival after
irradiation. Accordingly, we found that inhibition of
miR-125a had the respective negative effects, compar-
able to non-RT conditions.
miR-127 also was found to be down-regulated in irra-
diated cells. Originally it had been described as a puta-
tive tumor suppressor. It is silenced in tumor cells,
which causes the overexpression of the proto-oncogene
bcl-6 [21]. Likewise, we also found that the inhibition of
miRNA-127 reduced clonogenic survival (and prolifera-
tion; data not shown), suggesting that the anti-endothe-
lial radiation effects are associated with down-regulated
miR-127 levels. Conversely, over-expressed miR-127
enhanced radiation sensitivity in clonogenic assays. Per-
haps the executed signaling pathways are dependent on
the expression levels of other parameters suggesting a
functional ‘switch’ role of miRNA-127. Another explana-
tion would be that the downregulation of miRNA-127
after radiation is not functionally in line but rather part
of a negative feedback mechanism. Moreover, a dual
role of miRNAs has recently been described, showing
that a miRNA can repress or enhance mRNA transla-
tion, depending on the state of the cell cycle [22].
Further, it has been described that ionizing radiation
also may have dual roles with respect to endothelial cells,
angiogenesis and the microenvironment: while radiation
has dominantly direct anti-endothelial effects, it may also
convey indirect pro-angiogenic effects with up-regulation
of VEGF, PDGF or AKT signaling in endothelium. One
might speculate that miR-127 is involved in such or simi-
lar pro-survival mechanisms [13,23].
In the case of miR-148b irradiation down-regulated
expression levels. miR-148b inhibition itself slightly
reduced clonogenic growth. In contrast, and similarly to
the findings for miRNA-127, miR-148b inhibition might
favor survival under radiation conditions.
Conclusion
Taken together we have shown here that ionizing radia-
tion of HDMECs induces alterations of miRNA levels
with up- as well as down-regulations. We found that
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especially miR-189, let-7g, and miR-20a seem to play a
role in endothelial cell clonogenic survival and/or prolif-
eration, and to a weaker extend also miR-125a, -127,
and -148b. Furthermore, we show that alterations of
miRNA levels modify EC radiosensitivity. While in parti-
cular miR-189 and miR-125a have a protective effect on
endothelial cells, miR-127 and let-7g enhance their sen-
sitivity to irradiation. Since we performed our studies in
human primary endothelium as effector cells of angio-
genesis and tumor angiogenesis [24], it is conceivable
that the miRNAs identified here may also influence
angiogenesis in vivo in normal tissue and tumors. More-
over, with respect to carcinogenesis and cancer therapy,
radiation effects might be conveyed, modified or asso-
ciated with differential regulations of miRNAs. There-
fore, the modulation of miRNA levels may have
implications for anticancer treatments, in particular for
radiotherapy alone and in combination with drugs [25].
Additional file 1: List of miRNAs on the microarrays. The file contains
a list of miRNAs (Reporter ID, miRBase Entry and sequence) which were
spotted on the microarrays.
Additional file 2: Testing of various transfection conditions for
functional assays. HDMEC were transfected with miR-1 (Ambion), then
RNA was isolated and the expression of the PTK9 gene was measured by
real-time PCR (Roche Light Cycler 480). miR-1 is known to down-regulate
the PTK9 mRNA in human cells. Bar chart: Expression ratio of the PTK9
gene versus a reference gene (18S rRNA).
Additional file 3: Microarray data of let-7 family members from
HDMEC. Microarrays were performed of radiation treated (2 Gy) versus
untreated cells; t-test was done with 3 biological replicates each. Each
‘fold change’ value represents the mean of all spot values.
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